Drug discovery used to take 12 years and cost $2.6 billion on average to bring a single new treatment to market. That timeline is collapsing. AI models trained on protein structure data, genomic sequences, and vast libraries of existing compounds are identifying viable drug candidates in months rather than years. For physicians, this means a rapidly expanding toolkit of new treatments will reach clinical practice faster than at any point in the history of medicine. What AI Found That Humans Missed Several promising compounds for treatment-resistant depression, certain rare cancers, and antibiotic-resistant infections were identified by AI systems in 2024 and 2025 and are now in Phase 2 and Phase 3 trials. These are drugs that traditional research pipelines almost certainly would not have found for another decade, if at all. Precision Medicine Becomes Practical Medicine AI is also accelerating the translation of genomic data into clinical prescribing decisions. Pharmacogenomic AI tools can now tell a physician, at the point of prescribing, which antidepressant is most likely to be effective for a specific patient based on their genetic profile. This is personalised medicine becoming practical medicine in 2026. Staying Current in a Rapidly Evolving Landscape With new treatments entering clinical practice faster than ever, the burden on physicians to stay current with evidence is growing. AI clinical decision support tools embedded in platforms like Doctrust continuously update their recommendation engines with the latest published evidence, so physicians always have the most current guidance at the point of care. How Doctrust Can Help Doctors Doctrust keeps physicians at the leading edge of clinical evidence without requiring hours of journal reading. Its AI surfaces relevant new guidelines, drug approvals, and clinical alerts directly in the workflow when they are most relevant. You practice with the confidence of someone who has read everything, without having to read everything. Explore Doctrust at www.doctrust.in #DrugDiscovery #PrecisionMedicine #AIHealthcare #Doctrust #PharmacogenomicsAI #ClinicalEvidence #MedicalAI2026 #FutureTreatments